ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

ClinicalTrials.gov ID: NCT06356571

Public ClinicalTrials.gov record NCT06356571. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 5:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single-arm, Open-label, Phase 2 Study Evaluating Subcutaneous Administration of Isatuximab, Administered by an On Body Delivery System, in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Study identification

NCT ID
NCT06356571
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
64 participants

Conditions and interventions

Interventions

  • Acetaminophen Drug
  • Carfilzomib Drug
  • Dexamethasone Drug
  • Diphenhydramine Drug
  • Isatuximab SC-OBDS Drug
  • Methylprednisolone Drug
  • Montelukast Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2025
Primary completion
Jan 7, 2027
Completion
Jul 14, 2027
Last update posted
Feb 22, 2026

2025 – 2027

United States locations

U.S. sites
34
U.S. states
18
U.S. cities
32
Facility City State ZIP Site status
Mayo Clinic in Arizona - Phoenix- Site Number : 8400058 Phoenix Arizona 85054 Recruiting
Los Angeles Hematology Oncology Medical Group- Site Number : 8400027 Los Angeles California 90017 Recruiting
Private Practice - Dr. James R. Berenson- Site Number : 8400044 West Hollywood California 90069 Recruiting
Smilow Cancer Center at Yale-New Haven- Site Number : 8400020 New Haven Connecticut 06511 Recruiting
Maryland Oncology Hematology- Site Number : 8400038 Washington D.C. District of Columbia 20017 Recruiting
Life Clinical Trials - Coral Springs- Site Number : 8400055 Coral Springs Florida 33071 Recruiting
Center for Rheumatology, Immunology and Arthritis- Site Number : 8400031 Fort Lauderdale Florida 33309 Recruiting
Mayo Clinic in Florida- Site Number : 8400002 Jacksonville Florida 32224 Recruiting
The Oncology Institute of Hope & Innovation - Lakeland- Site Number : 8400054 Lakeland Florida 33812 Recruiting
D&H Pompano Research Center- Site Number : 8400049 Margate Florida 33063 Recruiting
Millennium Oncology - Pembroke Pines- Site Number : 8400011 Pembroke Pines Florida 33024 Recruiting
BRCR Global- Site Number : 8400008 Plantation Florida 33322 Recruiting
Florida Cancer Specialists - North- Site Number : 8400030 St. Petersburg Florida 33705 Recruiting
Pontchartrain Cancer Center - Covington- Site Number : 8400046 Covington Louisiana 70433 Recruiting
Beth Israel Deaconess Medical Center - Boston- Site Number : 8400005 Boston Massachusetts 02215 Recruiting
Michigan Hematology & Oncology Consultants - Dearborn- Site Number : 8400036 Dearborn Michigan 48126 Recruiting
Hematology Oncology Consultants - Royal Oak- Site Number : 8400039 Royal Oak Michigan 48073 Recruiting
Alliance for Multispeciality Research - Kansas City- Site Number : 8400056 Kansas City Missouri 64114 Recruiting
Washington University- Site Number : 8400007 St Louis Missouri 63110 Recruiting
Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400021 Hackensack New Jersey 07601 Recruiting
San Juan Oncology Associates- Site Number : 8400016 Farmington New Mexico 87401 Recruiting
Memorial Sloan Kettering Cancer Center - New York - York Avenue- Site Number : 8400003 New York New York 10065 Recruiting
Duke University Medical Center- Site Number : 8400018 Durham North Carolina 27710 Recruiting
Gabrail Cancer Center- Site Number : 8400010 Canton Ohio 44718 Recruiting
University of Cincinnati Medical Center- Site Number : 8400043 Cincinnati Ohio 45219 Recruiting
Oncology Hematology Care - Kenwood- Site Number : 8400014 Cincinnati Ohio 45236 Recruiting
Roper Saint Francis Healthcare- Site Number : 8400013 Charleston South Carolina 29401 Recruiting
Prisma Health Cancer Institute - Greenville- Site Number : 8400019 Greenville South Carolina 29615 Recruiting
Gibbs Cancer Center & Research Institute - Spartanburg- Site Number : 8400001 Spartanburg South Carolina 29303 Recruiting
Tennessee Cancer Specialists - Knoxville - Old Weisgarber Road- Site Number : 8400035 Knoxville Tennessee 37909 Recruiting
University of Tennessee Medical Center- Site Number : 8400006 Knoxville Tennessee 37920 Recruiting
Tennessee Oncology Nashville- Site Number : 8400012 Nashville Tennessee 37203 Recruiting
Northern Virginia Oncology Group- Site Number : 8400045 Fairfax Virginia 22031 Recruiting
SSM Health Dean Medical Group - Wisconsin - Madison- Site Number : 8400009 Madison Wisconsin 53715 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06356571, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06356571 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →